Africa CDC criticizes U.S. travel restrictions over the Bundibugyo Ebola outbreak
The Africa Centres for Disease Control and Prevention, Africa CDC, opposed broad U.S. travel restrictions introduced after the outbreak of Bundibugyo Ebola in the Democratic Republic of the Congo and Uganda. In a statement published on May 19, 2026, the organization said that it understands every state's right to protect public health and national security, but warned that general travel bans and intensified border measures should not be the fundamental response to epidemics. According to Africa CDC, public health measures should be guided by scientific evidence, proportionality, transparency, international cooperation and the rules of the International Health Regulations. The organization emphasized that the fastest path to protecting all countries lies in decisively suppressing the infection at its source, not in relying on borders as the main line of defense.
Africa CDC's reaction followed the tightening of travel warnings by U.S. authorities and the introduction of additional measures for people who had stayed in countries linked to the outbreak. On May 17, 2026, the U.S. State Department raised the travel advisory for the Democratic Republic of the Congo to the highest level, Level 4, because of the Bundibugyo Ebola outbreak in Ituri Province. On May 18, 2026, the U.S. CDC and the U.S. Department of Homeland Security announced that they were implementing enhanced health monitoring of travelers, entry restrictions and other public health measures to prevent the virus from being introduced into the United States. According to the CDC, no case connected with this outbreak has currently been confirmed in the United States.
Dispute over the scale of travel restrictions
In its statement, Africa CDC assessed that generalized travel bans and border closures can have the opposite effect from the one desired. The organization states that such measures can cause economic disruptions, discourage the timely reporting of cases, make humanitarian and health operations more difficult, and increase the movement of people through informal and less supervised routes. According to Africa CDC's position, this can create additional epidemiological risks, especially in areas where the population moves across borders on a daily basis. The organization therefore advocates targeted and time-limited solutions, including surveillance, testing, contact tracing, strengthening laboratory capacities and safe care for the sick.
The U.S. side explains the measures by the need to reduce the risk of the virus being introduced into the country while the epidemiological picture is changing rapidly. On May 19, the CDC announced that the overall risk to the U.S. public and travelers is low, but that additional precautionary measures are being implemented. According to the CDC, travelers going to the affected region should avoid contact with sick people, immediately report symptoms and follow official health instructions.
Outbreak declared an international public health threat
On May 17, 2026, the World Health Organization announced that the outbreak of disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda meets the criteria for a public health event of international concern. According to the WHO, by May 16, in Ituri Province in the Democratic Republic of the Congo, eight laboratory-confirmed cases, 246 suspected cases and 80 suspected deaths had been reported in at least three health zones, including Bunia, Rwampara and Mongbwalu. At the same time, the WHO stated that two laboratory cases had been confirmed in Kampala, Uganda, on May 15 and 16, including one fatal outcome, in people who had traveled from the Democratic Republic of the Congo. The organization emphasized that international spread has already been documented, which is why a coordinated response by states and partners is required.
The data continued to change after that. On May 19, the U.S. CDC, citing the ministries of health of the Democratic Republic of the Congo and Uganda, reported a total of 536 suspected cases, 105 probable cases, 34 confirmed cases and 134 deaths. In the same report, the CDC stated that 26 new confirmed cases and 143 new suspected cases had been recorded in the previous 24 to 48 hours. These data also include two confirmed cases in Uganda, including one fatal outcome, among people who had traveled from the Democratic Republic of the Congo, and according to the CDC, further local spread in Uganda had not been reported at that time. Since this is a developing epidemic, official institutions warn that the figures may be corrected as laboratory confirmations and additional epidemiological information arrive.
The WHO cited several factors as reasons for declaring an extraordinary international event. In the affected health zones, unusual clusters of deaths in the community were recorded with symptoms compatible with disease caused by Bundibugyo virus, and deaths of health workers were also reported in a clinical context suggesting viral hemorrhagic fever. The organization warned that this raises questions about transmission in health facilities, gaps in infection prevention and control, and the possible strengthening of the outbreak within the health system. The WHO also states that insecurity, the humanitarian crisis, high population mobility, urban and semi-urban hotspots and a network of informal health facilities further complicate the response.
Why the Bundibugyo strain is a particular challenge
Ebola is a severe, often fatal disease caused by infection with one of the orthoebolaviruses, a group of viruses that appear periodically in sub-Saharan Africa. According to the CDC, symptoms can appear from two to 21 days after contact with the virus, and on average develop eight to ten days after exposure. In the early phase, the disease can include fever, aches and fatigue, while in more severe phases vomiting, diarrhea and unexplained bleeding may occur. The CDC states that health workers and family members who care for sick people without appropriate protective and infection-control measures are at greatest risk.
Particular concern in the current outbreak is connected with the type of virus. It is Bundibugyo virus, a rarer cause of Ebola disease, for which there are currently no approved specific therapies or vaccines. According to the CDC, the fatality rate for disease caused by Bundibugyo virus ranges approximately from 25 to 50 percent, depending on the circumstances and the availability of supportive care. The CDC also states that two treatments for Ebola disease caused by the species Orthoebolavirus zairense have been approved in the United States, but that there are no approved therapies for other orthoebolaviruses, including Bundibugyo. According to the CDC, the approved vaccine against one type of Ebola is not considered effective for the spring 2026 outbreak caused by Bundibugyo virus.
Africa CDC identified precisely the absence of licensed vaccines and therapies for Bundibugyo as an example of structural imbalance in global health innovation. The organization states that this strain was identified almost two decades ago, yet medical countermeasures are still not available in the form of approved products. In its assessment, the WHO also emphasized that, unlike Zaire Ebola strains, there are currently no approved specific vaccines or therapies for Bundibugyo. In practice, this means that the response to the outbreak relies to a large extent on rapid case detection, isolation of the sick, contact tracing, protection of health workers and early supportive care.
Ituri as a hotspot under the pressure of a security and humanitarian crisis
According to the CDC, the outbreak in the Democratic Republic of the Congo was reported in nine health zones in Ituri Province, in the northeast of the country along the border with Uganda. This is an area where logistical access, security and health infrastructure have long been serious challenges. The CDC stated that the affected areas have limited transport infrastructure, difficult terrain and ongoing security problems, which can make it harder for outbreak response teams and medical personnel to arrive. The WHO additionally warned that the risk of spread is increasing because of humanitarian conditions, high population mobility and uncertainty about the actual number of infected people and the geographical reach of the outbreak.
In its assessment, the WHO warned that neighboring states sharing land borders with the Democratic Republic of the Congo face a high risk of further spread because of population movements, trade links, travel and epidemiological uncertainty. Two confirmed cases in Kampala among people who came from the Democratic Republic of the Congo showed that the virus can be transmitted across the border before the chain of transmission is fully understood. For this reason, public health experts emphasize the importance of cross-border cooperation, data exchange and harmonized surveillance protocols, not only unilateral travel restrictions.
U.S. doctor among those infected, risk to the United States assessed as low
On May 19, the CDC announced that one American, exposed to the virus while caring for patients in the Democratic Republic of the Congo, tested positive for Bundibugyo Ebola disease on May 17. According to the CDC, the person developed symptoms during the weekend, and U.S. authorities, in cooperation with the State Department, are working to transfer the patient to Germany for treatment and care. High-risk contacts linked to that exposure, according to the same source, are also being transferred to Germany.
The case of the infected U.S. health worker further increased public attention on the outbreak, but official U.S. assessments still emphasize a low risk for the broader public in the United States. In its frequently asked questions about Ebola, the CDC states that there are currently no cases in the United States connected with this outbreak and that the risk of spread in the United States is low. The agency emphasizes that viruses that cause Ebola disease pose a small risk to travelers and the general public, while those most at risk are people who care for the sick without adequate protection. Such an assessment does not exclude stricter precautionary measures for travelers and the health system, but it places the emphasis on targeted public health protocols.
At the center of the dispute between Africa CDC and the U.S. measures, therefore, is not the question of the seriousness of the disease, but the question of the effectiveness and proportionality of the response. Africa CDC believes that broad restrictions can undermine cooperation and transparency, while U.S. authorities argue that temporary measures reduce the possibility of the virus being introduced into the country during a period of increased uncertainty. Both sides acknowledge that the outbreak requires a coordinated response, and official WHO and CDC data show that the situation is developing rapidly and that the true scale of transmission is still being determined.
Africa CDC calls for stronger support for the response at the source of the outbreak
On May 15, 2026, after confirmation that at least two countries were affected, Africa CDC activated its continental mandate and declared the outbreak, stating that it wanted to raise political attention and accelerate coordination among African states. In its statement, the organization said that from the early stages of the outbreak it had acted quickly, transparently and responsibly, and that it maintained information exchange with governments, partners, the media and international stakeholders. Africa CDC also emphasized that the May 18 declaration of a public health emergency of continental security was aimed at mobilizing political leadership, resources and coordinated action, not at creating public panic.
In the statement, Africa CDC also referred to the meeting of the African High-Level Ministerial Panel on Global Health Architecture held in Geneva on May 17, 2026. According to the organization, ministers from 48 African countries agreed that future strategic negotiations on continental partnerships in the area of health security should increasingly be coordinated through Africa CDC. Such an approach, according to the organization's position, should strengthen African solidarity, policy alignment and the joint position of member states. In the context of the current outbreak, that message also has a broader meaning: Africa CDC is asking that international support not be reduced to restricting travel, but be directed toward laboratories, protective equipment, training, clinical care, surveillance and research into medical countermeasures.
In its recommendations for states in which the event is taking place, the WHO called for the activation of national disaster-management mechanisms and the establishment of emergency operations centers under high-level state leadership. The organization emphasized the need for coordination of partners and sectors so that measures to control Bundibugyo disease are implemented effectively and under supervision. In practice, this includes rapid detection and isolation of cases, protection of health facilities, contact tracing, communication with local communities and cross-border cooperation.
Travel restrictions cannot replace trust and surveillance
The debate over U.S. travel restrictions is taking place at a time when international health institutions are trying to prevent the outbreak from growing into a wider regional crisis. According to the WHO, the event requires international coordination in order to understand the scope of the outbreak, harmonize surveillance and prevention, and strengthen operations on the ground. According to the CDC, U.S. measures include enhanced surveillance and monitoring of travelers, but the agency itself simultaneously states that the risk to the U.S. public is low and that there are no confirmed cases in the United States. This combination of caution and low risk assessment shows how sensitive the issue of managing epidemics is when they unfold in areas with limited infrastructure and major international attention.
Africa CDC warns that countries affected by epidemics must not be punished for transparent disease reporting. If fear of economic consequences, border closures or stigmatization encourages the concealment of information, global health security may be weakened. That is why the organization is calling for the response to Bundibugyo Ebola to be based on trust, data exchange and investments in systems that can rapidly detect and stop transmission. As of May 20, 2026, official data indicate that the outbreak has most severely affected Ituri Province in the Democratic Republic of the Congo, with confirmed cases in Uganda linked to travel from Congo. Since there is no approved vaccine or specific treatment for Bundibugyo virus, the response will depend on the speed of laboratory confirmation, safe care, protection of health workers and the ability of local communities to accept public health measures.
Sources:
- Africa CDC / Zawya – statement on U.S. travel restrictions related to the Bundibugyo Ebola outbreak (link)
- U.S. Centers for Disease Control and Prevention – current summary on the Ebola outbreak in the Democratic Republic of the Congo and Uganda and U.S. measures (link)
- World Health Organization – decision on a public health event of international concern for the outbreak caused by Bundibugyo virus (link)
- U.S. Department of State – travel advisory for the Democratic Republic of the Congo, Level 4: Do Not Travel (link)
- U.S. Centers for Disease Control and Prevention – frequently asked questions about Ebola, symptoms, risk, treatment and vaccines (link)
- U.S. Centers for Disease Control and Prevention – statement on the CDC's international response to the outbreak in the DRC and Uganda (link)
- Travel Daily News – initial news item on Africa CDC's reaction to the U.S. travel advisory and travel restrictions (link)